Zobrazeno 1 - 10
of 77
pro vyhledávání: '"K. W. Kohn"'
Publikováno v:
Scopus-Elsevier
We demonstrate that the simian virus 40 genome contains a single MAR (matrix association region) that maps within a large T-antigen coding region (nucleotides 4071 to 4377). This region contains topoisomerase II cleavage sites, exhibits sequence simi
Publikováno v:
Cell biochemistry and biophysics. 33(2)
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(9)
Camptothecin (CPT) derivatives are topoisomerase I (top1) inhibitors recently introduced as clinical agents. To explore the role of p53 in CPT-induced cytotoxicity, we examined CPT effects in two isogenic pairs of human cancer cell lines, MCF-7 breas
Publikováno v:
Cancer research. 57(18)
7-Hydroxystaurosporine (UCN-01) is a selective protein kinase C inhibitor in clinical trial for cancer treatment. In this study, we found that nanomolar concentrations of camptothecin (CPT), a topoisomerase I inhibitor, arrest or delay cell cycle pro
Publikováno v:
Pharmaceutical research. 13(12)
A QSAR study based on electrotopological state (E-state) indices was conducted for a series of flavone HIV-1 integrase inhibitors to guide drug design.E-state indices formulated to encode electronic and topological information for each skeletal atom
Publikováno v:
Cancer research. 56(19)
Previous cell line comparisons indicated that neither S-phase fraction nor topoisomerase I (top1) levels are sufficient to predict camptothecin (CPT) cytotoxicity (F. Goldwasser el al., Cancer Res., 55: 2116-2121, 1995.). To identify new determinants
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 2(4)
Camptothecin (CPT) derivatives are presently in ongoing Phase I/II clinical trials. The interactions between 9-aminocamptothecin (9AC) and cisplatin (CDDP) have been studied in the IGROV-1 human ovarian cancer cell line used in the National Cancer In
Publikováno v:
Cancer research. 55(2)
We have studied changes in cyclin A- and B1-dependent kinases during apoptosis induced in human promyelocytic leukemia (HL60) cells treated with the topoisomerase I inhibitor camptothecin. We found that cyclin B1/Cdc2 kinase activity transiently incr
Autor:
K. W. Kohn, P. M. O’Connor
Publikováno v:
Cancer Treatment An Update ISBN: 9782817807676
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53465ce65da727de0e5e31293b84e8e7
https://doi.org/10.1007/978-2-8178-0765-2_16
https://doi.org/10.1007/978-2-8178-0765-2_16
Publikováno v:
Advances in pharmacology (San Diego, Calif.).